AIM IMMUNOTECH INC. Increase (Decrease) in Accounts Receivable, Related Parties
AIM IMMUNOTECH INC. (AIM) reported Increase (Decrease) in Accounts Receivable, Related Parties of -$314.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2021-03-31
- AIM IMMUNOTECH INC. increase (decrease) in accounts receivable, related parties for fiscal 2020 was -$314.00K, a 478.31% decline from fiscal 2019.
- AIM IMMUNOTECH INC. increase (decrease) in accounts receivable, related parties for fiscal 2019 was $83.00K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 12 month |
|---|---|
| 2020-12-31 | -$314.00K 10-K · filed 2021-03-31 |
| 2019-12-31 | $83.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |